Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response

Mylene T. Truong; Chitra Viswanathan; Jeremy J. Erasmus

doi:10.1097/RTI.0b013e3182128704

Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response

Mylene T. Truong, Chitra Viswanathan, Jeremy J. Erasmus

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Abstract

Positron emission tomography (PET)/computed tomographic scanning, using 18F-2-deoxy-D-glucose, complements conventional imaging evaluation of patients with lung cancer. The strength of PET scanning lies in the detection of nodal and extrathoracic metastases. PET scanning is also currently being studied in the assessment of prognosis and therapeutic response and has the potential to alter management of oncologic patients. This review will discuss the role of PET/computed tomographic scanning in the diagnosis, staging, and evaluation of prognosis and treatment response in patients with lung cancer.

Original language	English (US)
Pages (from-to)	132-146
Number of pages	15
Journal	Journal of Thoracic Imaging
Volume	26
Issue number	2
DOIs	https://doi.org/10.1097/RTI.0b013e3182128704
State	Published - May 2011

Keywords

Lung cancer
positron emission tomography/computed tomography
staging

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Pulmonary and Respiratory Medicine

Access to Document

10.1097/RTI.0b013e3182128704

Cite this

@article{15228a92ba9a4d84b3a2b5b45628ab53,

title = "Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response",

abstract = "Positron emission tomography (PET)/computed tomographic scanning, using 18F-2-deoxy-D-glucose, complements conventional imaging evaluation of patients with lung cancer. The strength of PET scanning lies in the detection of nodal and extrathoracic metastases. PET scanning is also currently being studied in the assessment of prognosis and therapeutic response and has the potential to alter management of oncologic patients. This review will discuss the role of PET/computed tomographic scanning in the diagnosis, staging, and evaluation of prognosis and treatment response in patients with lung cancer.",

keywords = "Lung cancer, positron emission tomography/computed tomography, staging",

author = "Truong, {Mylene T.} and Chitra Viswanathan and Erasmus, {Jeremy J.}",

year = "2011",

month = may,

doi = "10.1097/RTI.0b013e3182128704",

language = "English (US)",

volume = "26",

pages = "132--146",

journal = "Journal of Thoracic Imaging",

issn = "0883-5993",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response

AU - Truong, Mylene T.

AU - Viswanathan, Chitra

AU - Erasmus, Jeremy J.

PY - 2011/5

Y1 - 2011/5

N2 - Positron emission tomography (PET)/computed tomographic scanning, using 18F-2-deoxy-D-glucose, complements conventional imaging evaluation of patients with lung cancer. The strength of PET scanning lies in the detection of nodal and extrathoracic metastases. PET scanning is also currently being studied in the assessment of prognosis and therapeutic response and has the potential to alter management of oncologic patients. This review will discuss the role of PET/computed tomographic scanning in the diagnosis, staging, and evaluation of prognosis and treatment response in patients with lung cancer.

AB - Positron emission tomography (PET)/computed tomographic scanning, using 18F-2-deoxy-D-glucose, complements conventional imaging evaluation of patients with lung cancer. The strength of PET scanning lies in the detection of nodal and extrathoracic metastases. PET scanning is also currently being studied in the assessment of prognosis and therapeutic response and has the potential to alter management of oncologic patients. This review will discuss the role of PET/computed tomographic scanning in the diagnosis, staging, and evaluation of prognosis and treatment response in patients with lung cancer.

KW - Lung cancer

KW - positron emission tomography/computed tomography

KW - staging

UR - http://www.scopus.com/inward/record.url?scp=79955567637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955567637&partnerID=8YFLogxK

U2 - 10.1097/RTI.0b013e3182128704

DO - 10.1097/RTI.0b013e3182128704

M3 - Article

C2 - 21508735

AN - SCOPUS:79955567637

SN - 0883-5993

VL - 26

SP - 132

EP - 146

JO - Journal of Thoracic Imaging

JF - Journal of Thoracic Imaging

IS - 2

ER -

Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this